HBI Deals+Insights / Interviews
A pioneering blood test which helps clinicians diagnose bipolar disorder will come to market shortly. HBI catches up with Alexandra Prieux, CEO at France-based ALCEDIAG, which should be first to market with the first of what could be a series of tests.